GENEVA, Oct. 1 -- SHANGHAI INSTITUTE OF ORGANIC CHEMISTRY, CHINESE ACADEMY OF SCIENCES filed a patent application (CN2026/082641) for “USE OF RIPK1 MODULATOR IN TREATMENT OF ALZHEIMER'S DISEASE”. With publication no. WO/2026/189377, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: A61K 45/00
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....